Medical professionals around the world use NOW^® rapid in vitro diagnostic tests to identify the causative pathogens of infectious diseases. Our technologies detect bacteria and viruses causing upper and lower respiratory tract infections, including Legionnaires' disease, pneumonia, RSV and influenza, as well as pathogens causing filariasis and malaria. Rapid and accurate test results provide the foundation for pathogen-specific diagnosis, facilitating optimal patient management and infection control practices.

At Binax, we are focused on improving existing technologies while pursuing innovative strategies for expanding the NOW line of products. We are committed to providing rapid diagnostics for use in physician's offices, as well as hospital and reference laboratories.

NOW tests are developed and manufactured for global markets by Binax, Inc., a biotechnology firm headquartered in Scarborough, Maine, U.S.A.

As we are in the process of merging our branded sites, please follow these links to explore the Clearview and BioStar product portfolios.